BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 15867393)

  • 1. Tumor necrosis factor reduces brain tumor growth by enhancing macrophage recruitment and microcyst formation.
    Villeneuve J; Tremblay P; Vallières L
    Cancer Res; 2005 May; 65(9):3928-36. PubMed ID: 15867393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased glioma growth in mice depleted of macrophages.
    Galarneau H; Villeneuve J; Gowing G; Julien JP; Vallières L
    Cancer Res; 2007 Sep; 67(18):8874-81. PubMed ID: 17875729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TNF expressed by tumor-associated macrophages, but not microglia, can eliminate glioma.
    Nakagawa J; Saio M; Tamakawa N; Suwa T; Frey AB; Nonaka K; Umemura N; Imai H; Ouyang GF; Ohe N; Yano H; Yoshimura S; Iwama T; Takami T
    Int J Oncol; 2007 Apr; 30(4):803-11. PubMed ID: 17332918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colon cancer cell-derived tumor necrosis factor-alpha mediates the tumor growth-promoting response in macrophages by up-regulating the colony-stimulating factor-1 pathway.
    Zins K; Abraham D; Sioud M; Aharinejad S
    Cancer Res; 2007 Feb; 67(3):1038-45. PubMed ID: 17283136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microglial-macrophage synthesis of tumor necrosis factor after focal cerebral ischemia in mice is strain dependent.
    Lambertsen KL; Gregersen R; Finsen B
    J Cereb Blood Flow Metab; 2002 Jul; 22(7):785-97. PubMed ID: 12142564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of human glioma-infiltrating microglia/macrophages in mediating antitumor immune responses.
    Hussain SF; Yang D; Suki D; Aldape K; Grimm E; Heimberger AB
    Neuro Oncol; 2006 Jul; 8(3):261-79. PubMed ID: 16775224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-infiltrating myeloid-derived suppressor cells are pleiotropic-inflamed monocytes/macrophages that bear M1- and M2-type characteristics.
    Umemura N; Saio M; Suwa T; Kitoh Y; Bai J; Nonaka K; Ouyang GF; Okada M; Balazs M; Adany R; Shibata T; Takami T
    J Leukoc Biol; 2008 May; 83(5):1136-44. PubMed ID: 18285406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor necrosis factor-alpha promotes malignant pleural effusion.
    Stathopoulos GT; Kollintza A; Moschos C; Psallidas I; Sherrill TP; Pitsinos EN; Vassiliou S; Karatza M; Papiris SA; Graf D; Orphanidou D; Light RW; Roussos C; Blackwell TS; Kalomenidis I
    Cancer Res; 2007 Oct; 67(20):9825-34. PubMed ID: 17942913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells.
    Yang B; Wu X; Mao Y; Bao W; Gao L; Zhou P; Xie R; Zhou L; Zhu J
    Neurosurgery; 2009 Sep; 65(3):610-24; discussion 624. PubMed ID: 19687708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasminogen kringle 5-engineered glioma cells block migration of tumor-associated macrophages and suppress tumor vascularization and progression.
    Perri SR; Nalbantoglu J; Annabi B; Koty Z; Lejeune L; François M; Di Falco MR; Béliveau R; Galipeau J
    Cancer Res; 2005 Sep; 65(18):8359-65. PubMed ID: 16166313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TNF-alpha- and TRAIL-resistant glioma cells undergo autophagy-dependent cell death induced by activated microglia.
    Mora R; Abschuetz A; Kees T; Dokic I; Joschko N; Kleber S; Geibig R; Mosconi E; Zentgraf H; Martin-Villalba A; Régnier-Vigouroux A
    Glia; 2009 Apr; 57(5):561-81. PubMed ID: 18942750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stat3 inhibition activates tumor macrophages and abrogates glioma growth in mice.
    Zhang L; Alizadeh D; Van Handel M; Kortylewski M; Yu H; Badie B
    Glia; 2009 Oct; 57(13):1458-67. PubMed ID: 19306372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma.
    Kim SM; Lim JY; Park SI; Jeong CH; Oh JH; Jeong M; Oh W; Park SH; Sung YC; Jeun SS
    Cancer Res; 2008 Dec; 68(23):9614-23. PubMed ID: 19047138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor necrosis factor receptor 2-mediated tumor suppression is nitric oxide dependent and involves angiostasis.
    Zhao X; Mohaupt M; Jiang J; Liu S; Li B; Qin Z
    Cancer Res; 2007 May; 67(9):4443-50. PubMed ID: 17483359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skewing the Th cell phenotype toward Th1 alters the maturation of tumor-infiltrating mononuclear phagocytes.
    Nonaka K; Saio M; Suwa T; Frey AB; Umemura N; Imai H; Ouyang GF; Osada S; Balazs M; Adany R; Kawaguchi Y; Yoshida K; Takami T
    J Leukoc Biol; 2008 Sep; 84(3):679-88. PubMed ID: 18566103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble human p55 and p75 tumor necrosis factor receptors reverse spontaneous arthritis in transgenic mice expressing transmembrane tumor necrosis factor alpha.
    Edwards CK; Bendele AM; Reznikov LI; Fantuzzi G; Chlipala ES; Li L; Moldawer LL; Mountz JD; Li YY; Dinarello CA
    Arthritis Rheum; 2006 Sep; 54(9):2872-85. PubMed ID: 16947419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogene therapy as a treatment for malignant brain tumors in young mice.
    Glick RP; Lichtor T; Lin H; Tarlock K; Cohen EP
    J Neurosurg; 2006 Jul; 105(1 Suppl):65-70. PubMed ID: 16871873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significant modulation of macrophages associated cytokines TNF-α, VEGF and apoptotoic protein Bax, Bcl2 abrogates tumor cells.
    Kumar P; Chatterjee S; Acharya S; Kumari A; Chaudhuri S; Singh MK; Ghosh SN; Chaudhuri S
    Cell Immunol; 2013; 284(1-2):172-81. PubMed ID: 23994239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sox10 has a broad expression pattern in gliomas and enhances platelet-derived growth factor-B--induced gliomagenesis.
    Ferletta M; Uhrbom L; Olofsson T; Pontén F; Westermark B
    Mol Cancer Res; 2007 Sep; 5(9):891-7. PubMed ID: 17855658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of tumor-associated macrophages by the vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid induces an effective CD8+ T-cell-mediated antitumor immune response in murine models of lung cancer and mesothelioma.
    Jassar AS; Suzuki E; Kapoor V; Sun J; Silverberg MB; Cheung L; Burdick MD; Strieter RM; Ching LM; Kaiser LR; Albelda SM
    Cancer Res; 2005 Dec; 65(24):11752-61. PubMed ID: 16357188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.